title: Why is the pharmaceutical industry investing increasing amounts in health economic evaluations?
abstract: Over the last few years, the pharmaceutical industry has financed an increasing number of health economic evaluations. The purpose of this article is to describe how and why the pharmaceutical industry is applying health economic evaluations. Seven different fields of application are identified, and the varying reasons for use are discussed.
authors.forename: F
authors.initials: F
authors.lastname: Andersson
mesh_terms: D003132:Commerce; D003362:Cost-Benefit Analysis; D019049:Developed Countries; D016527:Drug Costs; D004341:Drug Evaluation / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D017850:Economics, Pharmaceutical / Q000458:organization & administration*; D005069:Evaluation Studies as Topic; D006801:Humans; D004366:Nonprescription Drugs / Q000191:economics; D009936:Organizational Innovation; D012051:Reimbursement Mechanisms
chemical_list: D004366:Nonprescription Drugs